Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
“Both buprenorphine and methadone treatment are associated with reduced overdose risk and improved maternal and fetal outcomes in pregnancy (19, 44, 51, 72).”
Sex and gender differences in substance use disorders
McHugh, R. K., Votaw, V. R., Sugarman, D. E., & Greenfield, S. F. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.012 · Cited by 1,076
Hudak, M. L., Tan, R. C., THE COMMITTEE ON DRUGS, THE COMMITTEE ON FETUS AND NEWBORN, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Neville, K. A., Paul, I. M., Van Den Anker, J. N., et al. (2012) · Pediatrics · doi:10.1542/peds.2011-3212 · Cited by 877
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Public health and international drug policy
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00619-x · Cited by 641
Kocherlakota, P. (2014) · Pediatrics · doi:10.1542/peds.2013-3524 · Cited by 612
Prenatal Substance Abuse: Short- and Long-term Effects on the Exposed Fetus
Behnke, M., Smith, V. C., COMMITTEE ON SUBSTANCE ABUSE, COMMITTEE ON FETUS AND NEWBORN, Behnke, M., Smith, V. C., Levy, S., Ammerman, S. D., Gonzalez, P. K., Ryan, S. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3931 · Cited by 604
Retention in medication-assisted treatment for opiate dependence: A systematic review
Timko, C., Schultz, N. R., Cucciare, M. A., Vittorio, L., & Garrison-Diehn, C. (2016) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1100960 · Cited by 489
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461
Hser, Y., Saxon, A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M., Jacobs, P., Teruya, C., McLaughlin, P., Wiest, K., et al. (2014) · Addiction · doi:10.1111/add.12333 · Cited by 455
“This finding is consistent with other controlled trials or observational (nonrandomized) studies, even including studies that focused on special populations such as pregnant patients [19].”
ResultThe ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
(2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000633 · Cited by 412
Neonatal Opioid Withdrawal Syndrome
Patrick, S. W., Barfield, W. D., Poindexter, B. B., COMMITTEE ON FETUS AND NEWBORN, C. O. S. U. A. P., Cummings, J., Hand, I., Adams-Chapman, I., Aucott, S. W., Puopolo, K. M., Goldsmith, J. P., et al. (2020) · Pediatrics · doi:10.1542/peds.2020-029074 · Cited by 363
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“A recent multicentre international RCT of buprenorphine and methadone in 175 pregnant opioid-dependent women (the MOTHER study) found that babies of mothers treated with buprenorphine had less severe neonatal abstinence symptoms requiring less medication and shorter stays in hospital (Jones et al., 2010) (1b).”
BackgroundMedication Treatment of Opioid Use Disorder
Bell, J., & Strang, J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.06.020 · Cited by 328
McQueen, K., & Murphy-Oikonen, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600879 · Cited by 324
Substance use during pregnancy
Forray, A. (2016) · F1000Research · doi:10.12688/f1000research.7645.1 · Cited by 311
Primary Care–Based Models for the Treatment of Opioid Use Disorder: A Scoping Review
Korthuis, P. T., McCarty, D., Weimer, M., Bougatsos, C., Blazina, I., Zakher, B., Grusing, S., Devine, B., & Chou, R. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2149 · Cited by 297
Methadone and Buprenorphine for the Management of Opioid Dependence in Pregnancy
Jones, H. E., Finnegan, L. P., & Kaltenbach, K. (2012) · Drugs · doi:10.2165/11632820-000000000-00000 · Cited by 289
Self-citationAn Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome
Grossman, M. R., Berkwitt, A. K., Osborn, R. R., Xu, Y., Esserman, D. A., Shapiro, E. D., & Bizzarro, M. J. (2017) · Pediatrics · doi:10.1542/peds.2016-3360 · Cited by 279
Neonatal Abstinence Syndrome and High School Performance
Oei, J. L., Melhuish, E., Uebel, H., Azzam, N., Breen, C., Burns, L., Hilder, L., Bajuk, B., Abdel-Latif, M. E., Ward, M., et al. (2017) · Pediatrics · doi:10.1542/peds.2016-2651 · Cited by 275
McAllister-Williams, R. H., Baldwin, D. S., Cantwell, R., Easter, A., Gilvarry, E., Glover, V., Green, L., Gregoire, A., Howard, L. M., Jones, I., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699361 · Cited by 271
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M., Salsitz, E. A., Wetterau, N., & Wyatt, S. A. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3182312983 · Cited by 266
Chou, R., Cruciani, R. A., Fiellin, D. A., Compton, P., Farrar, J. T., Haigney, M. C., Inturrisi, C., Knight, J. R., Otis-Green, S., Marcus, S. M., et al. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.01.494 · Cited by 262
Medication-Assisted Treatment With Methadone: Assessing the Evidence
Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300235 · Cited by 251
Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update
Brady, K. T., McCauley, J. L., & Back, S. E. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020262 · Cited by 249
Rooming-In to Treat Neonatal Abstinence Syndrome: Improved Family-Centered Care at Lower Cost
Holmes, A. V., Atwood, E. C., Whalen, B., Beliveau, J., Jarvis, J. D., Matulis, J. C., & Ralston, S. L. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2929 · Cited by 246
The United States opioid epidemic
Lyden, J., & Binswanger, I. A. (2019) · Seminars in Perinatology · doi:10.1053/j.semperi.2019.01.001 · Cited by 243
Reddy, U. M., Davis, J. M., Ren, Z., Greene, M. F., & for the Opioid Use in Pregnancy, N. A. S. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002054 · Cited by 242
Zedler, B. K., Mann, A. L., Kim, M. M., Amick, H. R., Joyce, A. R., Murrelle, E. L., & Jones, H. E. (2016) · Addiction · doi:10.1111/add.13462 · Cited by 240
Self-citationMaintenance agonist treatments for opiate dependent pregnant women
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub2 · Cited by 238
A Public Health Strategy for the Opioid Crisis
Saloner, B., McGinty, E. E., Beletsky, L., Bluthenthal, R., Beyrer, C., Botticelli, M., & Sherman, S. G. (2018) · Public Health Reports® · doi:10.1177/0033354918793627 · Cited by 236
Bonhomme, J., Shim, R. S., Gooden, R., Tysu, D., & Rust, G. (2012) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30175-9 · Cited by 233
Buprenorphine Treatment for Opioid Use Disorder: An Overview
Shulman, M., Wai, J. M., & Nunes, E. V. (2019) · CNS Drugs · doi:10.1007/s40263-019-00637-z · Cited by 213
Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
Thomas, C. P., Fullerton, C. A., Kim, M., Montejano, L., Lyman, D. R., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300256 · Cited by 208
Klaman, S. L., Isaacs, K., Leopold, A., Perpich, J., Hayashi, S., Vender, J., Campopiano, M., & Jones, H. E. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000308 · Cited by 197
Self-citationWachman, E. M., Hayes, M. J., Brown, M. S., Paul, J., Harvey-Wilkes, K., Terrin, N., Huggins, G. S., Aranda, J. V., & Davis, J. M. (2013) · JAMA · doi:10.1001/jama.2013.3411 · Cited by 197
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment
Wachman, E. M., Schiff, D. M., & Silverstein, M. (2018) · JAMA · doi:10.1001/jama.2018.2640 · Cited by 197
Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic
Krans, E. E., & Patrick, S. W. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001446 · Cited by 192
Medication Use and Pain Management in Pregnancy: A Critical Review
Black, E., Khor, K. E., Kennedy, D. S., Chutatape, A., Sharma, S. K., Vancaillie, T. G., & Demirkol, A. (2019) · Pain Practice · doi:10.1111/papr.12814 · Cited by 188
Schiff, D. M., Nielsen, T., Hoeppner, B. B., Terplan, M., Hansen, H., Bernson, D., Diop, H., Bharel, M., Krans, E. E., Selk, S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.5734 · Cited by 179
Prescription Opioids in Pregnancy and Birth Outcomes: A Review of the Literature
Desai, R., Brogly, S., & Yazdy, M. (2015) · Journal of Pediatric Genetics · doi:10.1055/s-0035-1556740 · Cited by 178
Buprenorphine treatment of opioid‐dependent pregnant women: a comprehensive review
Jones, H. E., Heil, S. H., Baewert, A., Arria, A. M., Kaltenbach, K., Martin, P. R., Coyle, M. G., Selby, P., Stine, S. M., & Fischer, G. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04035.x · Cited by 177
Self-citationConnery, H. S., McHugh, R. K., Reilly, M. E., Shin, S., & Greenfield, S. F. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000271 · Cited by 176
Desai, R. J., Huybrechts, K. F., Hernandez-Diaz, S., Mogun, H., Patorno, E., Kaltenbach, K., Kerzner, L. S., & Bateman, B. T. (2015) · BMJ · doi:10.1136/bmj.h2102 · Cited by 174
Self-citationSubstance Use in the Perinatal Period
Forray, A., & Foster, D. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0626-5 · Cited by 172
Ecker, J., Abuhamad, A., Hill, W., Bailit, J., Bateman, B. T., Berghella, V., Blake-Lamb, T., Guille, C., Landau, R., Minkoff, H., et al. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.03.022 · Cited by 169
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants
Welle-Strand, G. K., Skurtveit, S., Jansson, L. M., Bakstad, B., Bjarkø, L., & Ravndal, E. (2013) · Acta Paediatrica · doi:10.1111/apa.12378 · Cited by 169
Brogly, S. B., Saia, K. A., Walley, A. Y., Du, H. M., & Sebastiani, P. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu190 · Cited by 167
Methadone and perinatal outcomes: a retrospective cohort study
Cleary, B., Donnelly, J. M., Strawbridge, J., Gallagher, P., Fahey, T. P., White, M., & Murphy, D. J. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.10.004 · Cited by 166
Jansson, L. M., & Velez, M. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834fdc3a · Cited by 165
Neonatal Abstinence Syndrome: Treatment and Pediatric Outcomes
Logan, B. A., Brown, M. S., & Hayes, M. J. (2013) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31827feea4 · Cited by 164
Review of the assessment and management of neonatal abstinence syndrome
Bagley, S. M., Wachman, E. M., Holland, E., & Brogly, S. B. (2014) · Addiction Science & Clinical Practice · doi:10.1186/1940-0640-9-19 · Cited by 162
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
Suarez, E. A., Huybrechts, K. F., Straub, L., Hernández-Díaz, S., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B., Terplan, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203318 · Cited by 162
Self-citationNational trends in antidepressant medication treatment among publicly insured pregnant women
Huybrechts, K. F., Palmsten, K., Mogun, H., Kowal, M., Avorn, J., Setoguchi-Iwata, S., & Hernández-Díaz, S. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.12.010 · Cited by 161
Effect of Buprenorphine Dose on Treatment Outcome
Fareed, A., Vayalapalli, S., Casarella, J., & Drexler, K. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.642758 · Cited by 159
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
Kaltenbach, K. A., O’Grady, K. E., Heil, S. H., Salisbury, A. L., Coyle, M. G., Fischer, G., Martin, P., Stine, S. M., & Jones, H. E. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.11.030 · Cited by 159
Self-citationMaintenance agonist treatments for opiate-dependent pregnant women
Minozzi, S., Amato, L., Bellisario, C., Ferri, M., & Davoli, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub3 · Cited by 159
Opioid Dependency in Pregnancy and Length of Stay for Neonatal Abstinence Syndrome
Pritham, U. A., Paul, J. A., & Hayes, M. J. (2012) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2011.01330.x · Cited by 149
Opioids in pregnancy and neonatal abstinence syndrome
Stover, M. W., & Davis, J. M. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.08.013 · Cited by 147
Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving Treatment
Saia, K., Schiff, D. M., Wachman, E. M., Mehta, P., Vilkins, A. L., Sia, M., Price, J., Samura, T., DeAngelis, J., Jackson, C. V., et al. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0168-9 · Cited by 147
Improving Care for Neonatal Abstinence Syndrome
Patrick, S. W., Schumacher, R. E., Horbar, J. D., Buus‐Frank, M. E., Edwards, E. M., Morrow, K. A., Ferrelli, K. R., Picarillo, A. P., Gupta, M., & Soll, R. F. (2016) · PEDIATRICS · doi:10.1542/peds.2015-3835 · Cited by 145
Management of psychotropic drugs during pregnancy
Chisolm, M. S., & Payne, J. L. (2016) · BMJ · doi:10.1136/bmj.h5918 · Cited by 144
Prenatal methadone exposure is associated with altered neonatal brain development
Monnelly, V. J., Anblagan, D., Quigley, A. J., Blesa, M., Cooper, E. S., Mactier, H., Semple, S. I. K., Bastin, M. E., & Boardman, J. P. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.12.033 · Cited by 143
Opioid Use Disorders: Perioperative Management of a Special Population
Ward, E. N., Quaye, A., & Wilens, T. E. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003477 · Cited by 142
Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder
Patrick, S. W., Richards, M. R., Dupont, W. D., McNeer, E. A., Buntin, M. B., Martin, P., Davis, M. M., Davis, C. S., Hartmann, K. E., Leech, A. A., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13456 · Cited by 141
Self-citationWelle-Strand, G. K., Skurtveit, S. O., Jones, H. E., Waal, H., Bakstad, B., Bjarkø, L., & Ravndal, E. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.001 · Cited by 139
Self-citationBaldacchino, A., Arbuckle, K., Petrie, D., & McCowan, C. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-104 · Cited by 138
Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004–2011
Patrick, S. W., Kaplan, H. C., Passarella, M. A., Davis, M. M., & Lorch, S. A. (2014) · Journal of Perinatology · doi:10.1038/jp.2014.114 · Cited by 137
Increasing pregnancy-related use of prescribed opioid analgesics
EPSTEIN, R. A., Bobo, W. V., Martin, P., Morrow, J. A., Wang, W., Chandrasekhar, R., & Cooper, W. O. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.05.017 · Cited by 135
Self-citationSedatives for opiate withdrawal in newborn infants
Osborn, D. A., Jeffery, H. E., & Cole, M. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002053.pub3 · Cited by 135
Evidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
van den Brink, W. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010003 · Cited by 128
Saxon, A. J., Ling, W. W., Hillhouse, M. P., Thomas, C., Hasson, A. L., Ang, A., Doraimani, G., Tasissa, G., Lokhnygina, Y. V., Leimberger, J., et al. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.08.002 · Cited by 128
Epidemiology of Substance Use in Reproductive-Age Women
McHugh, R. K., Wigderson, S. B., & Greenfield, S. F. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.02.001 · Cited by 125
Kennedy‐Hendricks, A., McGinty, E. E., & Barry, C. L. (2016) · Journal of Health Politics Policy and Law · doi:10.1215/03616878-3632230 · Cited by 123
Kaltenbach, K. A., Holbrook, A. M., Coyle, M. G., Heil, S. H., Salisbury, A. L., Stine, S. M., Martin, P., & Jones, H. E. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04038.x · Cited by 123
Self-citationDuber, H. C., Barata, I. A., Cioè‐Peña, E., Liang, S. Y., Ketcham, E. M., Macias‐Konstantopoulos, W., Ryan, S. A., Stavros, M., & Whiteside, L. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.04.007 · Cited by 120
Impact of Parental Presence at Infants’ Bedside on Neonatal Abstinence Syndrome
Howard, M. B., Schiff, D. M., Penwill, N. Y., Si, W., Rai, A., Wolfgang, T. L., Moses, J. M., & Wachman, E. M. (2017) · Hospital Pediatrics · doi:10.1542/hpeds.2016-0147 · Cited by 114
The economic burden of neonatal abstinence syndrome in the United States
Corr, T. E., & Hollenbeak, C. S. (2017) · Addiction · doi:10.1111/add.13842 · Cited by 114
No. 349-Substance Use in Pregnancy
Ordean, A., Wong, S., & Graves, L. E. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.04.028 · Cited by 114
Davis, J. M., Shenberger, J. S., Terrin, N. C., Breeze, J. L., Hudak, M. L., Wachman, E. M., Marro, P. J., Oliveira, É. L., Harvey-Wilkes, K. B., Czynski, A. J., et al. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.1307 · Cited by 112
Birth and Neonatal Outcomes following Opioid Use in Pregnancy: A Danish Population-Based Study
Nørgaard, M., Nielsson, M. S., & Heide‐Jørgensen, U. (2015) · Substance Abuse Research and Treatment · doi:10.4137/sart.s23547 · Cited by 111
Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder
Krans, E. E., Kim, J. Y., James, A. E., Kelley, D., & Jarlenski, M. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003231 · Cited by 111
Reduction in Length of Stay and Morphine Use for NAS With the “Eat, Sleep, Console” Method
Blount, T. J., Painter, A. E., Freeman, E. L., Grossman, M., & Sutton, A. G. (2019) · Hospital Pediatrics · doi:10.1542/hpeds.2018-0238 · Cited by 111
Wilder, C., Lewis, D., & Winhusen, T. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.02.012 · Cited by 109
Barriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States
Patrick, S. W., Buntin, M. B., Martin, P., Scott, T. A., Dupont, W. D., Richards, M. R., & Cooper, W. O. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1488336 · Cited by 109
Self-citationMethadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study
Meyer, M. C., Johnston, A., Crocker, A. M., & Heil, S. H. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000092 · Cited by 108
Self-citationBuprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy
Wiegand, S. L., Stringer, E. M., Stuebe, A. M., Jones, H. E., Seashore, C. J., & Thorp, J. M. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000640 · Cited by 107
Self-citationEndogenous opiates and behavior: 2006
Bodnar, R. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.002 · Cited by 104
Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes
Jones, H. E., Heil, S. H., Tuten, M., Chisolm, M. S., Foster, J. M., O’Grady, K. E., & Kaltenbach, K. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.019 · Cited by 104
Self-citationLong-Term Outcomes of Infants with Neonatal Abstinence Syndrome
Maguire, D. J., Taylor, S., Armstrong, K. H., Shaffer‐Hudkins, E., Germain, A. M., Brooks, S. S., Cline, G. J., & Clark, L. (2016) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.35.5.277 · Cited by 104
Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
Srivastava, A., Kahan, M., & Nader, M. (2017) · PubMed · Cited by 104
Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations
Krans, E. E., Cochran, G., & Bogen, D. L. (2015) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000098 · Cited by 102
Monnelly, V. J., Hamilton, R., Chappell, F. M., Mactier, H., & Boardman, J. P. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14117 · Cited by 101
Wide Variation Found in Care of Opioid-Exposed Newborns
Bogen, D. L., Whalen, B. L., Kair, L. R., Vining, M. A., & King, B. (2016) · Academic Pediatrics · doi:10.1016/j.acap.2016.10.003 · Cited by 100
Brown, M. S., Hayes, M. J., & Thornton, L. (2014) · Journal of Perinatology · doi:10.1038/jp.2014.194 · Cited by 99
Gaalema, D. E., Scott, T. L., Heil, S. H., Coyle, M. G., Kaltenbach, K. A., Badger, G. J., Arria, A. M., Stine, S. M., Martin, P., & Jones, H. E. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04039.x · Cited by 98
Self-citationSoto, E. E., Bahado-Singh, R. O., CHRISTENSEN, C. W., Chauhan, S. P., Sibai, B. M., & Viteri, O. A. (2014) · American Journal of Perinatology · doi:10.1055/s-0034-1393932 · Cited by 96
Breastfeeding Promotion for Management of Neonatal Abstinence Syndrome
Pritham, U. A. (2013) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/1552-6909.12242 · Cited by 96
Patrick, S. W., Faherty, L. J., Dick, A. W., Scott, T. A., Dudley, J. A., & Stein, B. D. (2019) · JAMA · doi:10.1001/jama.2018.20851 · Cited by 94
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.